发明名称 |
Method of preventing or treating influenza A viral infection using cloned DI influenza A viral particles |
摘要 |
Cloned, i.e. defined, defective interfering (DI) influenza A virus is produced in embryonated hens eggs using a method which generates large quantities of DI virus material. Co-administration of cloned DI influenza A virus with a lethal dose of virulent influenza A virus conferred protection in mice compared to a control of inactivated cloned DI influenza A virus. Control mice which received only cloned DI influenza A virus and no lethal challenge of virulent influenza A virus were not protected three weeks later on lethal challenge with infective virus. Cloned DI influenza A virus of one subtype is found to act in vivo as an effective antiviral against the same or any other sub-type of influenza A virus. The antiviral effect has been found to have both a therapeutic and a prophylactic application against influenza A infection in humans, mammals and birds. |
申请公布号 |
US9089516(B2) |
申请公布日期 |
2015.07.28 |
申请号 |
US201213712045 |
申请日期 |
2012.12.12 |
申请人 |
The University of Warwick |
发明人 |
Dimmock Nigel |
分类号 |
A61K35/12;A61K39/145;A61K35/76;C07K14/005;C12N7/00;A61K39/00 |
主分类号 |
A61K35/12 |
代理机构 |
King & Schickli, PLLC |
代理人 |
King & Schickli, PLLC |
主权项 |
1. A method for preventing or treating influenza A in a subject comprising administering an effective amount of a cloned defective interfering (DI) influenza A virus particle, wherein the cloned DI influenza A virus particle comprises an RNA segment 1 of the cloned DI influenza A virus;
further wherein the RNA segment 1 comprises a nucleic acid sequence consisting of (a) a sequence selected from SEQ ID NO: 1 or SEQ ID NO: 2; or (b) a nucleic acid sequence having at least 90% sequence identity with SEQ ID NO: 1. |
地址 |
Coventry GB |